Author:
Walley Alexander Y.,Alperen Julie K.,Cheng Debbie M.,Botticelli Michael,Castro-Donlan Carolyn,Samet Jeffrey H.,Alford Daniel P.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Center for Substance Abuse Treatment, Substance Abuse Treatment and Mental Health Services Administration, US Department of Health and Human Services. The determinations report: A report on the physician waiver program established by the Drug Addiction Treatment Act of 2000 (“DATA”). Available at: buprenorphine.samhsa.gov/SAMHSA_Determinations_Report.pdf. Accessed: May 16, 2008.
2. Kakko J, Svanborg KD, Kreek MJ, Heilig M. One-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361(9358):662–8.
3. Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22(2):171–6.
4. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005;20(11):1038–41.
5. Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5(2):146–50.
Cited by
183 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献